Viatris stock sheds 1.27% and underperforms market

6 articles · Updated · MarketWatch · May 8

Shares closed at $17.17 on Friday as the S&P 500 rose 0.84% to 7,398.93 and the Dow Jones Industrial Average edged up 0.02% to 49,609.16.
The decline ended a five-day winning streak for the drugmaker's stock.
Even after the drop, Viatris finished 1.60% below its 52-week high of $17.45 set on May 7, while trading volume reached 19.5 million against a 50-day average of 11.3 million.

Viatris beat earnings expectations, so why did its stock suddenly tumble?

Is Viatris a deeply undervalued opportunity or just a classic value trap?